At a glance
ClinicalIndex Comparison RecordN/ACompleted· 158 enrolled
Drug / intervention
CT-101-M +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification
In Brief
A clinical study evaluating CT-101-M and QuitGuide for Smoking Cessation and 7 related conditions. Completed, enrolled 158 participants across 1 site.
Detailed Summary
This study is comparing the efficacy of two smoking cessation apps.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation, Nicotine Addiction, Drug Addiction, Drug Dependence, Tobacco Dependence, Tobacco Use Disorder, Substance Use Disorder, Tobacco Smoking
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 2018
Enrollment StartOct 2018
Primary CompletionMar 2019
TodayJul 2026
First PostedOct 3, 2018
Enrollment StartOct 24, 2018
Primary CompletionMar 14, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.7 years ago
Interventions
CT-101-Mdevice
Mobile Application
QuitGuidedevice
Mobile Application